The Journal of Pharma and Drug Innovation (JPDI) is dedicated to advancing scholarly research in pharmaceutical and drug development sciences. The journal publishes original research articles, review articles, short communications, and case studies related to drug discovery, formulation science, pharmacological evaluation, and therapeutic research.

JPDI focuses on emerging developments in drug delivery systems, pharmaceutical chemistry, pharmacokinetics, regulatory science, and pharmaceutical biotechnology, with the objective of supporting the translation of research findings into healthcare and pharmaceutical applications.

The journal welcomes interdisciplinary contributions that integrate pharmacy, medicine, chemistry, biotechnology, and life sciences to address current challenges in pharmaceutical research and clinical therapeutics.

Areas of interest include:

• Drug design, discovery, and development
• Advanced and targeted drug delivery systems
• Pharmacology and pharmacodynamics
• Pharmaceutical formulation and quality assurance
• Clinical pharmacology and therapeutic innovations
• Natural product drug development and toxicological studies
• Nanomedicine and biosimilar development
• Regulatory science, GMP compliance, and pharmacovigilance
• Rational drug use, healthcare policy, and patient safety

Through the dissemination of evidence-based research, JPDI aims to support pharmaceutical research, therapeutic innovation, and public health advancement. The journal encourages collaboration among researchers, academicians, healthcare professionals, and industry experts worldwide.